Publications by authors named "Michael A Fridrik"

11Publications

ASCO update on lymphoma.

Memo 2017 24;10(4):218-219. Epub 2017 Nov 24.

Department of Internal Medicine 3, Centre for Hematology and Medical Oncology, Kepler University Hospital, Krankenhausstraße 9, 4021 Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0372-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725511PMC
November 2017

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.

Anticancer Res 2017 10;37(10):5553-5558

IIIrd Medical Department at the Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11987DOI Listing
October 2017

Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.

Anticancer Res 2015 Jan;35(1):517-21

3rd Medical Department with Haematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Centre, Salzburg Cancer Research Institute (SCRI) with the Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR) and the Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT), Paracelsus Medical University Salzburg, Salzburg, Austria

View Article

Download full-text PDF

Source
January 2015

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.

Invest New Drugs 2015 Apr 23;33(2):409-22. Epub 2014 Dec 23.

Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) - LB Cluster Translational Oncology and Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna), Third Medical Department, Center for Oncology and Hematology, Kaiser-Franz-Josef-Spital, Vienna, Austria,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0201-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387274PMC
April 2015

Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.

Ann Hematol 2010 Mar 20;89(3):273-82. Epub 2009 Aug 20.

Department Internal Medicine 3, Centre for Hematology and Medical Oncology, General Hospital Linz, Krankenhausstrasse 9, 4020, Linz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-009-0811-xDOI Listing
March 2010

Is the statistical difference clinically relevant?

J Clin Oncol 2005 Nov;23(33):8537; author reply 8537-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.6525DOI Listing
November 2005